Close

Press Releases

Lonza Completes Expansion of Microbial Manufacturing Facility in Visp

Lonza, a global partner to the pharmaceutical, biotech, and nutraceutical markets, announced that it has completed a planned expansion of the mid-scale microbial manufacturing facility at its Visp (CH) site. This multi-product facility was recently granted a GMP license...

Andrew MacGarvey & Conditor Capital Launch Coronado Research to maximise the use of data and technology in drug development; Dr Nicholas Edwards announced as...

Coronado Research is a consultancy-led, professional services organisation operating in the clinical development arena. The company will help pharmaceutical and biotechnology companies optimise their drug development programs by maximising the use of data and technology, and by joining the dots...

CPHI Milan Announce Pharma Award finalists

CPHI Milan (8-10 October, 2024) announces the finalists for the upcoming CPHI Pharma Awards, which will be hosted on the event’s opening evening at the CPHI Celebration. The awards are a key feature of the ‘CPHI Celebration’ and will commence with a glamorous drinks reception, celebrating excellence and innovation in...

Expert Speaker Line-Up Revealed for Industry-Leading RBQM Event

CluePoints, the premier sponsor of RBQMLive and provider of Risk-Based Quality Management (RBQM) and Data Quality Oversight Software, has revealed the full agenda and speaker line up for the award-winning RBQMLive event. RBQMLive is the industry-leading event for anyone working with, or interested in risk-based quality management approaches. RBQMLive, taking place...

Global CDMO brings technological advancements & significant capacity to Ocean County, NJ location

Renaissance Lakewood, LLC (“Renaissance”), a leading pharmaceutical contract development and manufacturing organization (CDMO), today announced the official opening of their new, 67,000 sq ft, expansive warehouse at their recently opened headquarters at 1215 Paco Way in Lakewood, NJ. The structure, at 81,000 sq...

Introducing ReciPredict: Revolutionising Drug Product Development and Manufacturing

30-70% API consumption reduction during development and scale up Reduce time to clinical stage by up to 6 months, speeding up development process Fully integrated approach to Quality by Design Today, Recipharm announced the launch of ReciPredict, a cutting-edge...

APL and CurifyLabs partnership to support critically ill patients with 3D printing medicine technology

APL, one of the largest manufacturers of extemporaneous medicines and a leading contract development and manufacturing organization (CDMO) in Sweden, has joined forces with CurifyLabs, a Finnish health tech company creating personalized medicine manufacturing solutions, to improve the administration of medicines to...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read